Drug Repurposing in Pharmaceutical Industry and Its Impact on Market Access: Market Access Implications

Journal of Market Access & Health Policy
doi 10.3402/jmahp.v2.22814
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PHP16 Generic Drug Market Access in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Trial Design and Market Access Implications: Outcomes From Comparator Choice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Role of Health Technology Assessment in Pharmaceutical Market Access in Developed Countries

English

Labor Market and Access to Justice

International Review of Law and Economics
LawFinanceEconomicsEconometrics
2018English

Pcn240 - All-Comers vs. Biomarker Based Patient Selection for Biotherapies in Oncology: Impact on Drug Development and Market Access

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Early Market Access Pathways in Europe and Japan: Current Development and Implications on Reimbursement and Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Access to Medicines and European Market Integration

SSRN Electronic Journal
2016English

Nature of Endpoints in Market Access Agreements

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pcp62 - Market Access Under Agile Circumstances

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy